NO902029L - Fremgangsmaate for fremstilling av heterocyklylguanidiner. - Google Patents

Fremgangsmaate for fremstilling av heterocyklylguanidiner.

Info

Publication number
NO902029L
NO902029L NO90902029A NO902029A NO902029L NO 902029 L NO902029 L NO 902029L NO 90902029 A NO90902029 A NO 90902029A NO 902029 A NO902029 A NO 902029A NO 902029 L NO902029 L NO 902029L
Authority
NO
Norway
Prior art keywords
methyl
carbon atoms
indol
hydrogen
phenyl
Prior art date
Application number
NO90902029A
Other languages
English (en)
Norwegian (no)
Other versions
NO902029D0 (no
Inventor
Arthur Adam Nagel
James Patrick Rizzi
Terry Jay Rosen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO902029D0 publication Critical patent/NO902029D0/no
Publication of NO902029L publication Critical patent/NO902029L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO90902029A 1989-05-19 1990-05-08 Fremgangsmaate for fremstilling av heterocyklylguanidiner. NO902029L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,189 US4963689A (en) 1989-05-19 1989-05-19 Heterocyclicguanidines as 5HT3 antagonists

Publications (2)

Publication Number Publication Date
NO902029D0 NO902029D0 (no) 1990-05-08
NO902029L true NO902029L (no) 1990-11-12

Family

ID=23371270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902029A NO902029L (no) 1989-05-19 1990-05-08 Fremgangsmaate for fremstilling av heterocyklylguanidiner.

Country Status (19)

Country Link
US (1) US4963689A (de)
EP (1) EP0397364B1 (de)
JP (1) JPH0635454B2 (de)
KR (1) KR920003927B1 (de)
AT (1) ATE92062T1 (de)
AU (1) AU615385B2 (de)
CA (1) CA2016182C (de)
DE (1) DE69002384T2 (de)
DK (1) DK0397364T3 (de)
ES (1) ES2058795T3 (de)
FI (1) FI902291A0 (de)
HU (1) HUT58063A (de)
IE (1) IE62935B1 (de)
IL (1) IL94254A (de)
MY (1) MY105555A (de)
NO (1) NO902029L (de)
NZ (1) NZ233576A (de)
PT (1) PT93979B (de)
ZA (1) ZA903478B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140034A (en) * 1989-03-14 1992-08-18 Merck Sharp & Dohme Ltd. Five-membered ring systems with bonded imidazolyl ring substituents
NZ255580A (en) * 1992-09-14 1997-08-22 Yamanouchi Pharma Co Ltd 2-(imidazolyl)alkylene-condensed thiazole derivatives and pharmaceutical compositions
KR970701705A (ko) * 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ 수용체 효능제, 신규한 티아졸 유도체 및 이의 중간체(5-HT₃receptor agonist, novel thiazole derivative, and intermediate therefor)
US5887415A (en) * 1995-05-11 1999-03-30 Bernard Matthews Plc Cooked, extruded meat product comprising additive
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
DE102005027193A1 (de) * 2005-06-06 2006-12-07 Wilhelm Stahlecker Gmbh Zwillingseinheit mit zwei Streckwerken für eine Spinnmaschine
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
DK2432467T3 (en) 2009-05-20 2018-04-16 Inst Nat Sante Rech Med SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS FOR USE IN TREATMENT OF VESTIBULAR DAMAGE LESSONS
EP2919788A4 (de) 2012-11-14 2016-05-25 Univ Johns Hopkins Verfahren und zusammensetzungen zur behandlung von schizophrenie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031165A (en) * 1965-08-18 1966-05-25 Wellcome Found Guanidines, isoureas and isothioureas
GB1305549A (de) * 1969-10-29 1973-02-07
DE2739723A1 (de) * 1977-09-03 1979-03-08 Merck Patent Gmbh 2-guanidinomethyl-indoline und verfahren zu ihrer herstellung
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds

Also Published As

Publication number Publication date
NZ233576A (en) 1991-06-25
MY105555A (en) 1994-10-31
FI902291A0 (fi) 1990-05-08
NO902029D0 (no) 1990-05-08
ES2058795T3 (es) 1994-11-01
KR900018054A (ko) 1990-12-20
PT93979A (pt) 1991-01-08
HU902976D0 (en) 1990-09-28
AU5476790A (en) 1990-11-15
KR920003927B1 (ko) 1992-05-18
AU615385B2 (en) 1991-09-26
JPH0635454B2 (ja) 1994-05-11
DE69002384T2 (de) 1993-11-18
CA2016182C (en) 1996-03-12
ZA903478B (en) 1991-12-24
IL94254A (en) 1994-05-30
DE69002384D1 (de) 1993-09-02
IE62935B1 (en) 1995-03-08
IE901664L (en) 1990-11-09
EP0397364B1 (de) 1993-07-28
PT93979B (pt) 1996-11-29
EP0397364A1 (de) 1990-11-14
ATE92062T1 (de) 1993-08-15
JPH0311070A (ja) 1991-01-18
HUT58063A (en) 1992-01-28
DK0397364T3 (da) 1993-09-27
CA2016182A1 (en) 1990-11-09
US4963689A (en) 1990-10-16

Similar Documents

Publication Publication Date Title
CA2084193A1 (en) 3-amino-2-aryl quinuclidines
DE60005504D1 (de) Chinolinderivate als mek enzym-inhibitoren
ES2062354T3 (es) Ariltiazolilimidazoles como antagonistas de 5ht3.
DE60011895D1 (de) Heterocyclische subtituierte aminoazacyclische verbindungen mit zentraler nervensystemwirkung
NO902029L (no) Fremgangsmaate for fremstilling av heterocyklylguanidiner.
ATE13885T1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel.
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
NO147877C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-oksazepin-derivater
NO903230L (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
KR910016694A (ko) 티오카르바모일아세토니트릴 화합물
TH1357B (th) 2-ออกซ์อินโดล ที่ถูกแทนที่ที่ตำแหน่ง 1 และ 3 ในฐานะสารแก้ปวดและต่อต้านการอักเสบ